China Expands Grant-to-Equity Financing to Commercialize Early-Stage Tech

Chinese regional authorities are broadening experiments with 'invest first, take equity later' financing mechanisms to help early-stage hard-technology startups bridge the commercialization gap. Under this model, initial fiscal support is provided as research project grants, which convert into equity stakes once the startup achieves market validation and secures subsequent private funding rounds. The approach aims to overcome traditional venture capital reluctance toward unproven, long-cycle technologies while reforming legacy government grant systems.

Bridging the commercialization gap for deep tech is critical for China's industrial upgrading and technological self-reliance. By sharing upfront technical and trial risks, state funds can mobilize private capital into hard technologies that otherwise face market failure during their earliest incubation phases.

Chinese local authorities are accelerating pilot programs for a funding model known as 'invest first, take equity later' (先投后股) to help early-stage deep-technology innovations cross the valley of death between laboratory research and commercial production, according to a report by People's Daily. First promoted in 2021 by the National Development and Reform Commission and the Ministry of Science and Technology, the mechanism is being tested in regions including Shanghai, Jiangsu, and Shandong under variations such as 'grant-to-investment' and 'grant-equity combination.' Under the model, local government funding is initially disbursed as a research grant. Once the technology achieves agreed milestones and attracts market-oriented private financing, the initial public funding converts into an equity stake managed and exited according to commercial standards. The framework is designed to address systemic bottlenecks in commercializing hard technology. Early-stage ventures frequently encounter three critical hurdles: technical uncertainty during pilot testing and validation, prolonged return timelines typically extending three to five years without revenue, and elevated failure rates across manufacturing iteration and market adoption, according to Pei Yawen, an official at the Shandong Provincial Science and Technology Department. Private venture capital in China has historically gravitated toward mature business models, proven cash flows, and rapid consumer-market applications, leaving pre-revenue deep-tech startups underfunded. Traditional government support also struggled to fill the void, as legacy fiscal subsidies were often distributed thinly across numerous applicants without market-oriented evaluation or long-term operational engagement. Case studies cited by People's Daily highlight how the hybrid funding structure has supported companies developing core technologies, such as high-precision motion control systems for humanoid robotics in Jiangsu, additive manufacturing in Shandong, and active anionic polymerization materials in Shanghai. By absorbing technical risks during the pre-commercial phase, regional authorities aim to derisk projects enough to crowd in private venture capital for subsequent growth stages.